These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15160803)

  • 1. Disease management programs in Germany's statutory health insurance system.
    Busse R
    Health Aff (Millwood); 2004; 23(3):56-67. PubMed ID: 15160803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk structure compensation in Germany's statutory health insurance.
    Busse R
    Eur J Public Health; 2001 Jun; 11(2):174-7. PubMed ID: 11420805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The German Central Health Fund-recent developments in health care financing in Germany.
    Göpffarth D; Henke KD
    Health Policy; 2013 Mar; 109(3):246-52. PubMed ID: 23200602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The German health-care system.
    Wahner-Roedler DL; Knuth P; Juchems RH
    Mayo Clin Proc; 1997 Nov; 72(11):1061-8. PubMed ID: 9374983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Switching sickness funds and risk compensation mechanisms in the statutory health insurance system in Germany--empirical results from the cooperative health research in the region of Augsburg (KORA)].
    Werner A; Reitmeir P; John J
    Gesundheitswesen; 2005 Aug; 67 Suppl 1():S158-66. PubMed ID: 16032535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease management and health care reforms in Germany - does more competition lead to less solidarity?
    Stock SA; Redaelli M; Lauterbach KW
    Health Policy; 2007 Jan; 80(1):86-96. PubMed ID: 16600418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free choice of sickness funds: economic implications and ethical aspects of the 1992 health care reform in Germany.
    Cassel D; Boroch W
    J Med Philos; 1995 Dec; 20(6):657-67. PubMed ID: 8861572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The population perspective in assessing the performance of Germany's health care system: Results of a cross-sectional survey among members of a statutory health insurance].
    Hengel P; Köppen J; Achstetter K; Blümel M; Haltaufderheide M; Busse R
    Z Evid Fortbild Qual Gesundhwes; 2024 Jun; 187():22-33. PubMed ID: 38824093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Disease management programs from a health insurer's point of view].
    Szymkowiak C; Walkenhorst K; Straub C
    Z Arztl Fortbild Qualitatssich; 2003 Jun; 97(3):201-6. PubMed ID: 12856546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Health economic evaluation of disease management programs].
    Greiner W
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Jan; 49(1):34-9. PubMed ID: 16320012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germany: Health system review.
    Busse R; Blümel M
    Health Syst Transit; 2014; 16(2):1-296, xxi. PubMed ID: 25115137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germany's health care system: it's not the American way.
    Reinhardt UE
    Health Aff (Millwood); 1994; 13(4):22-4. PubMed ID: 7989001
    [No Abstract]   [Full Text] [Related]  

  • 13. Price elasticities in the German Statutory Health Insurance market before and after the health care reform of 2009.
    Pendzialek JB; Danner M; Simic D; Stock S
    Health Policy; 2015 May; 119(5):654-63. PubMed ID: 25670009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free choice of sickness funds in regulated competition: evidence from Germany and The Netherlands.
    Gress S; Groenewegen P; Kerssens J; Braun B; Wasem J
    Health Policy; 2002 Jun; 60(3):235-54. PubMed ID: 11965333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences in treatment patterns of six chronic diseases: an analysis from the German statutory health insurance.
    Stock SA; Stollenwerk B; Redaelli M; Civello D; Lauterbach KW
    J Womens Health (Larchmt); 2008 Apr; 17(3):343-54. PubMed ID: 18338965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of selection inventives for health insurances after introduction of the morbidity-oriented risk compensation scheme: an empirical analysis].
    Lüngen M; Drabik A; Büscher G; Passon A; Siegel M; Stock S
    Gesundheitswesen; 2010 Nov; 72(11):790-6. PubMed ID: 20104447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring customer preferences in the German statutory health insurance.
    Pendzialek JB; Simic D; Stock S
    Eur J Health Econ; 2017 Sep; 18(7):831-845. PubMed ID: 27655398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Declared dead? Recommendations regarding integrated care from the perspective of German statutory health insurance].
    Amelung V; Wolf S; Ozegowski S; Eble S; Hildebrandt H; Knieps F; Lägel R; Schlenker RU; Sjuts R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Apr; 58(4-5):352-9. PubMed ID: 25776522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Introduction of disease management programmes in Germany as reflected by differing interests of health insurance companies and the federal association of statutory health insurance physicians].
    Erler A
    Gesundheitswesen; 2002 Nov; 64(11):572-7. PubMed ID: 12442215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nine good reasons to sign the initiative].
    Rev Med Suisse; 2011 Feb; 7(281):366-7. PubMed ID: 21416717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.